Fan F Zhang

6PUBLICATIONS
30CO-AUTHORS
Infant and child healthNeurology and neuromuscular diseasesPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 02, 2025
Long-Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group.

Hetal Dholaria, Arlene Naranjo, Fan F Zhang

|May 06, 2024
Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group.

Puja J Umaretiya, Arlene Naranjo, Fan F Zhang

|Apr 25, 2023
Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.

Hannah G Bender, Meredith S Irwin, Michael D Hogarty

|Feb 07, 2023
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.

Navin Pinto, Arlene Naranjo, Xiangming Ding

|Jul 28, 2021
Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.

Meredith S Irwin, Arlene Naranjo, Fan F Zhang

|May 24, 2021
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.

Brian D Weiss, Gregory Yanik, Arlene Naranjo

Pageof 1

Frequent Collaborators

4 joint publications

Rochelle Bagatell

4 joint publications

Meredith S Irwin

3 joint publications

Michael D Hogarty

3 joint publications

Arlene Naranjo